Structure |
Chemical Name |
CAS |
MF |
![4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID](../cas/gif/31166-29-7.gif) |
4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID |
31166-29-7 |
C5H2Cl2O2S |
![N,O-Dibenzylated formoterol](../cas/gif/43229-70-5.gif) |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
![Entacapone](../) |
Entacapone |
|
|
![nifedipine iMpurity](../cas/20180703/gif/cb93033129.gif) |
nifedipine iMpurity |
|
C19H22N2O6 |
![Linagliptin Impurity A](../) |
Linagliptin Impurity A |
|
|
![Dehydropitavastatin ethyl ester](../cas/20210111/gif/254452-91-0.gif) |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
![(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide](../cas/20180703/gif/357338-13-7.gif) |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
![Linagliptin Impurity V](../) |
Linagliptin Impurity V |
|
|
![methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate](../cas/20180703/gif/1181267-33-3.gif) |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
![(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol](../cas/20180703/gif/150194-52-8.gif) |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](../cas/20180703/gif/cb93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
![Etoricoxib Impurity 18](../) |
Etoricoxib Impurity 18 |
|
|
![Ibrutinib Impurity 4](../cas/20210111/gif/1807619-68-6.gif) |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
![Imatinib Impurity 3](../) |
Imatinib Impurity 3 |
|
|
![Mirabegron Impurity 16](../) |
Mirabegron Impurity 16 |
|
|
![Olaparib Impurity 2](../) |
Olaparib Impurity 2 |
|
|
![Sofosbuvir Impurity 7](../cas/20200611/gif/1884385-12-9.gif) |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
![Vonoprazan Impurity 3](../cas/20200611/gif/928325-41-1.gif) |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
![Cinacalcet Impurity 22](../) |
Cinacalcet Impurity 22 |
|
|
![Dapagliflozin Impurity C](../) |
Dapagliflozin Impurity C |
|
|
![Dasatinib Impurity E](../) |
Dasatinib Impurity E |
|
|
![Ixazomib Impurity](../) |
Ixazomib Impurity |
|
|
![Nevirapine Impurity](../) |
Nevirapine Impurity |
|
|
![Omarigliptin Impurity](../cas/20210111/gif/1819364-01-6.gif) |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
![Palbociclib Impurity 8](../cas/20180808/gif/827022-31-1.gif) |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
![Sitagliptin EP Impurity C](../cas/20180808/gif/1345822-86-7.gif) |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
![Trifluridine Impurity](../) |
Trifluridine Impurity |
2086328-10-9 |
|
![Valsartan related compound H](../) |
Valsartan related compound H |
|
|
![Vildagliptin Related Compound H](../cas/20200611/gif/2253194-13-5.gif) |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
![Moxifloxacin Impurity 7](../) |
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](../cas/20180703/gif/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
![Merariveron impurity D](../cas/gif/cb93053655.gif) |
Merariveron impurity D |
|
C26H28N6O3S2 |
![Cefazolin impurity E](../) |
Cefazolin impurity E |
|
|
![Lamivudine Impurity Mixture](../) |
Lamivudine Impurity Mixture |
|
|
![Rifaximin impurity B](../cas/20211123/gif/1351775-04-6.gif) |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
![4-(3-(Piperidin-1-yl)propoxy)benzoic acid](../cas/20180703/gif/767286-87-3.gif) |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
![5-Chloro-3-sulfino-2-thiophenecarboxylic acid](../cas/20180703/gif/187746-97-0.gif) |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](../cas/20180703/gif/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
![methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](../cas/20180703/gif/cb93116219.gif) |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
![Isavuconazole Impurity 11](../cas/20211123/gif/2732924-99-9.gif) |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
![Levosimendan Impurity 2](../cas/20210111/gif/103416-88-2.gif) |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
![Aprepitant EP Impurity B](../cas/20200611/gif/2206606-86-0.gif) |
Aprepitant EP Impurity B |
2206606-86-0 |
C29H25F7N4O3 |
![Famotidine EP Impurity A](../cas/20180703/gif/88061-72-7.gif) |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |
![Meloxicam EP Impurity D](../cas/20180808/gif/1331636-17-9.gif) |
Meloxicam EP Impurity D |
1331636-17-9 |
C16H17N3O4S2 |
![Erythromycin Impurity](../cas/20210111/gif/40554-78-7.gif) |
Erythromycin Impurity |
40554-78-7 |
C37H65NO12 |
![Fluconazole EP Impurity I](../cas/20180808/gif/150168-54-0.gif) |
Fluconazole EP Impurity I |
150168-54-0 |
C13H14BrF2N7O |
![1-benzyl-2-methyl-1H-imidazole-carbaldehyde](../cas/20180703/gif/39269-74-4.gif) |
1-benzyl-2-methyl-1H-imidazole-carbaldehyde |
39269-74-4 |
C12H12N2O |
![Sacubitril Impurity](../cas/20200611/gif/1015037-46-3.gif) |
Sacubitril Impurity |
1015037-46-3 |
C23H27NO4 |
![Desloratadine Impurity](../cas/20210111/gif/50603-12-8.gif) |
Desloratadine Impurity |
50603-12-8 |
C20H21N |
![Olaparib Impurity H](../) |
Olaparib Impurity H |
|
|
![Brexpiprazole Impurity B](../) |
Brexpiprazole Impurity B |
|
|
![Dapoxetine iMpurity 6](../) |
Dapoxetine iMpurity 6 |
|
|
![Irbesartan Impurity 4](../cas/20200401/gif/cb93127103.gif) |
Irbesartan Impurity 4 |
|
C25H28N6O |
![2-cyclopentylidene-2-phenylacetic acid](../cas/20200401/gif/cb93127224.gif) |
2-cyclopentylidene-2-phenylacetic acid |
|
C13H14O2 |
![Cabozantinib impurity B](../) |
Cabozantinib impurity B |
|
|
![Metoprolol IMpurity 3](../cas/20200401/gif/cb93127587.gif) |
Metoprolol IMpurity 3 |
|
C15H25NO3 |
![Mirabegron Impurity 1](../) |
Mirabegron Impurity 1 |
|
|
![Desfluoro Pitavastatin Calcium](../cas/20200515/gif/847849-67-6.gif) |
Desfluoro Pitavastatin Calcium |
847849-67-6 |
C25H25NO4 |
![Plerixafor](../cas/20200611/gif/548488-49-9.gif) |
Plerixafor |
548488-49-9 |
C12H23F3N4O |
![Vonoprazan Impurity 10](../) |
Vonoprazan Impurity 10 |
|
|
![Vonoprazan Impurity 5](../) |
Vonoprazan Impurity 5 |
|
|
![Sitagliptin IMpurity 1](../) |
Sitagliptin IMpurity 1 |
|
|
![Etoricoxib Impurity 7](../) |
Etoricoxib Impurity 7 |
|
|
![Ezetimibe Impurity D](../) |
Ezetimibe Impurity D |
|
|
![Alogliptin Imp.13](../) |
Alogliptin Imp.13 |
|
|
![Erlotinib Imp.18](../) |
Erlotinib Imp.18 |
|
|
![Ezetimibe (RSS)-Isomer](../cas/20180703/gif/1478664-18-4.gif) |
Ezetimibe (RSS)-Isomer |
1478664-18-4 |
C24H21F2NO3 |
![Apremilast Impurity 6](../) |
Apremilast Impurity 6 |
|
|
![Azilsartan Impurity 16](../cas/20210305/gif/1417576-00-1.gif) |
Azilsartan Impurity 16 |
1417576-00-1 |
C28H20N4O8 |
![Regorafenib Impurity 11](../cas/20211123/gif/2512204-88-3.gif) |
Regorafenib Impurity 11 |
2512204-88-3 |
C19H18ClFN4O3 |
![Topiroxostat Impurity 2](../cas/20180808/gif/445218-61-1.gif) |
Topiroxostat Impurity 2 |
445218-61-1 |
C12H11N5O |
![Fluvastatin Impurity 1](../cas/20200401/gif/cb93129576.gif) |
Fluvastatin Impurity 1 |
|
C24H26FNO4 |
![Lornoxicam Impurity 7](../) |
Lornoxicam Impurity 7 |
|
|
![Prednisolone Impurity A](../cas/20200401/gif/cb93130026.gif) |
Prednisolone Impurity A |
|
C21H28O5 |
![Tofacitinib Impurity 6](../cas/20211123/gif/1640972-35-5.gif) |
Tofacitinib Impurity 6 |
1640972-35-5 |
C16H22N6O |
![Afatinib Impurity 20](../) |
Afatinib Impurity 20 |
|
|
![1-(4-Ethylphenyl)-2-methyl-2-propen-1-one](../cas/20180703/gif/70639-76-8.gif) |
1-(4-Ethylphenyl)-2-methyl-2-propen-1-one |
70639-76-8 |
C12H14O |
![Ceftriaxone Sodium impurity](../) |
Ceftriaxone Sodium impurity |
|
|
![Ivabradine Impurity 5](../cas/20200515/gif/1462470-54-7.gif) |
Ivabradine Impurity 5 |
1462470-54-7 |
C27H38N2O6 |
![Aprepitant Impurity 6](../cas/20200611/gif/170902-81-5.gif) |
Aprepitant Impurity 6 |
170902-81-5 |
C23H21F7N4O3 |
![(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxy-2-((E)-4-hydroxybenzylidene)pentanoyl)-4-phenyloxazolidin-2-one](../cas/20180703/gif/cb93152233.gif) |
(S)-3-((R)-5-(4-fluorophenyl)-5-hydroxy-2-((E)-4-hydroxybenzylidene)pentanoyl)-4-phenyloxazolidin-2-one |
|
C27H24FNO5 |
![Alogliptin Related Compound 14](../cas/20200611/gif/1820685-30-0.gif) |
Alogliptin Related Compound 14 |
1820685-30-0 |
C18H23N5O3 |
![(3S,5S)-Atorvastatin (sodium salt)](../cas/20180703/gif/1428118-38-0.gif) |
(3S,5S)-Atorvastatin (sodium salt) |
1428118-38-0 |
C33H36FN2NaO5 |
![Chlorpromazine EP impurity B](../cas/20180808/gif/19077-2d20-4.gif) |
Chlorpromazine EP impurity B |
19077-20-4 |
C21H28ClN3S |
![2-amino-4-fluoro-5-nitrobenzoic acid](../cas/20180703/gif/1194097-41-0.gif) |
2-amino-4-fluoro-5-nitrobenzoic acid |
1194097-41-0 |
C7H5FN2O4 |
![Alogliptin benzoate impurity K](../cas/20210111/gif/1618644-32-8.gif) |
Alogliptin benzoate impurity K |
1618644-32-8 |
C25H25N5O3 |
![Belinostat Z-isomer](../cas/20210111/gif/1884227-58-0.gif) |
Belinostat Z-isomer |
1884227-58-0 |
C15H14N2O4S |
![Canagliflozin Impurity 13](../) |
Canagliflozin Impurity 13 |
|
|
![Carfilzomib Impurity 1](../) |
Carfilzomib Impurity 1 |
|
|
![Dapagliflozin Impurity 14](../cas/20210111/gif/2271248-78-1.gif) |
Dapagliflozin Impurity 14 |
2271248-78-1 |
C21H25ClO6 |
![Ibrutinib Impurity 13](../) |
Ibrutinib Impurity 13 |
|
|
![Linagliptin Impurity 26](../cas/20210305/gif/2446799-71-7.gif) |
Linagliptin Impurity 26 |
2446799-71-7 |
C20H17BrN6O2 |
![Nintedanib Impurity 13 (Intedanib Impurity 13)](../) |
Nintedanib Impurity 13 (Intedanib Impurity 13) |
|
|
![vildagliptin Impurity E](../cas/20200611/gif/1789703-37-2.gif) |
vildagliptin Impurity E |
1789703-37-2 |
C17H25N3O2 |
![Sitagliptin Impurity 1](../cas/20180906/gif/823817-55-6.gif) |
Sitagliptin Impurity 1 |
823817-55-6 |
C16H15F6N5O |
![Niraparib metabolite M1](../cas/20180808/gif/1476777-06-6.gif) |
Niraparib metabolite M1 |
1476777-06-6 |
C19H19N3O2 |
![Amlodipine Impurity 16](../cas/20180703/gif/cb93159166.gif) |
Amlodipine Impurity 16 |
|
C26H31ClN2O8S |
![Edoxaban Impurity 11 (1R,2R,4S)](../cas/20200611/gif/480451-98-7.gif) |
Edoxaban Impurity 11 (1R,2R,4S) |
480451-98-7 |
C21H30ClN5O5 |
![Rivaroxaban Impurity 25](../cas/20210111/gif/931117-61-2.gif) |
Rivaroxaban Impurity 25 |
931117-61-2 |
C19H21Cl2N3O6S |
![(R)-CITALOPRAM R-(+)-1-3-(dimethyl-amino) propyl-1-(p-fluorophenyl)-5-phthalancarbonitrile](../) |
(R)-CITALOPRAM R-(+)-1-3-(dimethyl-amino) propyl-1-(p-fluorophenyl)-5-phthalancarbonitrile |
|
|